Molecular and Genetic Medicine

University Hospital A Meyer, Florence, Italy

Publications

• Research Article   
  Whole-Body MRI and Whole Body [123I]-I-mIBG Scintigraphy: a Comparison in Intermediate and High Risk Neuroblastoma and validation of SIOPEN Scoring System in WB-MRI
  Author(s): Olianti C*, Perrone A, Allocca M, Di Maurizio M, Carra F, La Cava G and Tondo A
  
  Purpose: To assess the agreement between 123I-metaiodobenzylguanidine or [123I]-I-mIBG and Whole Body Magnetic Resonance Imaging with diffusion-weighted whole-body imaging with background body signal suppression (WB MRI-DWIBS) in High and Intermediate risk Neuroblastoma, a retrospective review was performed on [123I]-I-mIBG and DWIBS paired scans acquired at diagnosis, response-to-therapy, after-surgery, off therapy and after relapse with systemic involvement, and osteo-bone marrow metastatic load was evaluated for each of them. Methods: 80 paired [123I]-I-mIBG and DWIBS scans were acquired for 31 patients between June 2009 and June 2019 within 30 days and without intercurrent therapy. SIOPEN Semi-quantitative Scoring Systems for NB with 12 body sections was applied at whole body MIBG and WB MRI-DWIBS acquired to evaluate the .. Read More»
  DOI: 10.37421/1747-0862.2021.15.505

  Abstract HTML PDF